Disseminated phaeohyphomycosis: Review of an emerging mycosis

Pharmacology, Toxicology and Pharmaceutical Science

• Fungus 100%
• Infection 100%
• Phaeohyphomycosis 66%
• Case Report 66%
• Combination Therapy 33%
• Mycosis 33%
• Immunocompromised Patient 33%
• Eosinophilia 33%
• Endocarditis 33%
• Antifungal Agent 33%
• Mortality Rate 33%
• Virulence Factor 33%
• Pig 33%
• Lomentospora prolificans 33%
• Melanin 33%
• Host 33%

Medicine and Dentistry

• Infection 100%
• Phaeohyphomycosis 66%
• Patient 66%
• Antifungal Therapy 33%
• Antifungal Agent 33%
• Combination Therapy 33%
• Mycosis 33%
• Mortality Rate 33%
• Virulence Factor 33%
• Cell Wall 33%
• Immunity 33%
• Endocarditis 33%
• Immunocompromised Patient 33%
• Eosinophilia 33%
• Heart Valve Bioprosthesis 33%
• Development 33%
• Melanin 33%
• Host 33%